IBA signs MoU with University of Pennsylvania for two ProteusONE proton therapy systems

IBA has signed a Memorandum of Understanding with the University of Pennsylvania Health System for the installation of two ProteusONE compact proton therapy solutions at Penn Presbyterian Medical Center in Philadelphia. The final contract is expected later in 2024, with patient treatments expected to start in 2027.

“We are pleased to continue and strengthen the long-lasting partnership with the University of Pennsylvania and be part of their proton therapy expansion plan.”biospace.com

• 1 source
• biospace.comIBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutionsTristan ManalacAug 27, 2024

Summarized from public sources; check the original articles before acting on it.